Patient subjective assessment of drug side effects in inflammatory bowel disease

Raymond K. Cross, Oleg Lapshin, Joseph Finkelstein

Research output: Contribution to journalArticle

Abstract

BACKGROUND AND GOALS: Side effects occur with every class of inflammatory bowel disease (IBD) medication. Our goal was to assess IBD patients' subjective assessment of drug side effects using the [Sid]e [e]ffects [s]urvey (SidES), a survey instrument that we previously developed and tested in patients with asthma and psychiatric disorders. STUDY: Disease activity, quality of life, and adherence was assessed in adult outpatients with IBD. SidES assesses the number, severity, and duration of side effects. Prescription and over the counter medications were evaluated. RESULTS: Thirty-nine patients from the University of Maryland IBD program participated. Twenty-two patients with Crohn's disease, 12 with ulcerative colitis, and 7 with indeterminate colitis were evaluated. Twenty-seven patients reported drug side effects, of which 56% reported changes in medical management. Disease activity increased, medication number increased, and quality of life decreased with increasing side effects scores. The number of medications and IBD drugs, use of steroids, and use of neuropsychiatrics correlated with side effects scores. Side effects scores negatively correlated with the quality of life. CONCLUSIONS: Side effects were common in patients with IBD from a tertiary referral center. Side effects are not trivial for they can result in alterations in the medical regimen and are associated with increased disease activity and decreased quality of life scores. The total number of medications and use of neuropsychiatric drugs and steroids are correlated with side effects scores. Given the difficulty that patients have in determining whether a symptom is related to a particular drug or from a medical condition, further prospective studies are needed to evaluate the impact of patient assessment of side effects on clinical outcomes in IBD.

Original languageEnglish (US)
Pages (from-to)244-251
Number of pages8
JournalJournal of Clinical Gastroenterology
Volume42
Issue number3
DOIs
StatePublished - Mar 2008
Externally publishedYes

Fingerprint

Drug-Related Side Effects and Adverse Reactions
Inflammatory Bowel Diseases
Quality of Life
Steroids
Pharmaceutical Preparations
Colitis
Ulcerative Colitis
Tertiary Care Centers
Crohn Disease
Prescriptions
Psychiatry
Outpatients
Asthma
Prospective Studies

Keywords

  • Adverse drug reactions
  • Adverse effects
  • Inflammatory bowel disease
  • Side effects

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Patient subjective assessment of drug side effects in inflammatory bowel disease. / Cross, Raymond K.; Lapshin, Oleg; Finkelstein, Joseph.

In: Journal of Clinical Gastroenterology, Vol. 42, No. 3, 03.2008, p. 244-251.

Research output: Contribution to journalArticle

Cross, Raymond K. ; Lapshin, Oleg ; Finkelstein, Joseph. / Patient subjective assessment of drug side effects in inflammatory bowel disease. In: Journal of Clinical Gastroenterology. 2008 ; Vol. 42, No. 3. pp. 244-251.
@article{f70954c8ae9b43daa342c1e5034bdb4c,
title = "Patient subjective assessment of drug side effects in inflammatory bowel disease",
abstract = "BACKGROUND AND GOALS: Side effects occur with every class of inflammatory bowel disease (IBD) medication. Our goal was to assess IBD patients' subjective assessment of drug side effects using the [Sid]e [e]ffects [s]urvey (SidES), a survey instrument that we previously developed and tested in patients with asthma and psychiatric disorders. STUDY: Disease activity, quality of life, and adherence was assessed in adult outpatients with IBD. SidES assesses the number, severity, and duration of side effects. Prescription and over the counter medications were evaluated. RESULTS: Thirty-nine patients from the University of Maryland IBD program participated. Twenty-two patients with Crohn's disease, 12 with ulcerative colitis, and 7 with indeterminate colitis were evaluated. Twenty-seven patients reported drug side effects, of which 56{\%} reported changes in medical management. Disease activity increased, medication number increased, and quality of life decreased with increasing side effects scores. The number of medications and IBD drugs, use of steroids, and use of neuropsychiatrics correlated with side effects scores. Side effects scores negatively correlated with the quality of life. CONCLUSIONS: Side effects were common in patients with IBD from a tertiary referral center. Side effects are not trivial for they can result in alterations in the medical regimen and are associated with increased disease activity and decreased quality of life scores. The total number of medications and use of neuropsychiatric drugs and steroids are correlated with side effects scores. Given the difficulty that patients have in determining whether a symptom is related to a particular drug or from a medical condition, further prospective studies are needed to evaluate the impact of patient assessment of side effects on clinical outcomes in IBD.",
keywords = "Adverse drug reactions, Adverse effects, Inflammatory bowel disease, Side effects",
author = "Cross, {Raymond K.} and Oleg Lapshin and Joseph Finkelstein",
year = "2008",
month = "3",
doi = "10.1097/MCG.0b013e31802f19af",
language = "English (US)",
volume = "42",
pages = "244--251",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Patient subjective assessment of drug side effects in inflammatory bowel disease

AU - Cross, Raymond K.

AU - Lapshin, Oleg

AU - Finkelstein, Joseph

PY - 2008/3

Y1 - 2008/3

N2 - BACKGROUND AND GOALS: Side effects occur with every class of inflammatory bowel disease (IBD) medication. Our goal was to assess IBD patients' subjective assessment of drug side effects using the [Sid]e [e]ffects [s]urvey (SidES), a survey instrument that we previously developed and tested in patients with asthma and psychiatric disorders. STUDY: Disease activity, quality of life, and adherence was assessed in adult outpatients with IBD. SidES assesses the number, severity, and duration of side effects. Prescription and over the counter medications were evaluated. RESULTS: Thirty-nine patients from the University of Maryland IBD program participated. Twenty-two patients with Crohn's disease, 12 with ulcerative colitis, and 7 with indeterminate colitis were evaluated. Twenty-seven patients reported drug side effects, of which 56% reported changes in medical management. Disease activity increased, medication number increased, and quality of life decreased with increasing side effects scores. The number of medications and IBD drugs, use of steroids, and use of neuropsychiatrics correlated with side effects scores. Side effects scores negatively correlated with the quality of life. CONCLUSIONS: Side effects were common in patients with IBD from a tertiary referral center. Side effects are not trivial for they can result in alterations in the medical regimen and are associated with increased disease activity and decreased quality of life scores. The total number of medications and use of neuropsychiatric drugs and steroids are correlated with side effects scores. Given the difficulty that patients have in determining whether a symptom is related to a particular drug or from a medical condition, further prospective studies are needed to evaluate the impact of patient assessment of side effects on clinical outcomes in IBD.

AB - BACKGROUND AND GOALS: Side effects occur with every class of inflammatory bowel disease (IBD) medication. Our goal was to assess IBD patients' subjective assessment of drug side effects using the [Sid]e [e]ffects [s]urvey (SidES), a survey instrument that we previously developed and tested in patients with asthma and psychiatric disorders. STUDY: Disease activity, quality of life, and adherence was assessed in adult outpatients with IBD. SidES assesses the number, severity, and duration of side effects. Prescription and over the counter medications were evaluated. RESULTS: Thirty-nine patients from the University of Maryland IBD program participated. Twenty-two patients with Crohn's disease, 12 with ulcerative colitis, and 7 with indeterminate colitis were evaluated. Twenty-seven patients reported drug side effects, of which 56% reported changes in medical management. Disease activity increased, medication number increased, and quality of life decreased with increasing side effects scores. The number of medications and IBD drugs, use of steroids, and use of neuropsychiatrics correlated with side effects scores. Side effects scores negatively correlated with the quality of life. CONCLUSIONS: Side effects were common in patients with IBD from a tertiary referral center. Side effects are not trivial for they can result in alterations in the medical regimen and are associated with increased disease activity and decreased quality of life scores. The total number of medications and use of neuropsychiatric drugs and steroids are correlated with side effects scores. Given the difficulty that patients have in determining whether a symptom is related to a particular drug or from a medical condition, further prospective studies are needed to evaluate the impact of patient assessment of side effects on clinical outcomes in IBD.

KW - Adverse drug reactions

KW - Adverse effects

KW - Inflammatory bowel disease

KW - Side effects

UR - http://www.scopus.com/inward/record.url?scp=39749114984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749114984&partnerID=8YFLogxK

U2 - 10.1097/MCG.0b013e31802f19af

DO - 10.1097/MCG.0b013e31802f19af

M3 - Article

C2 - 18223502

AN - SCOPUS:39749114984

VL - 42

SP - 244

EP - 251

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 3

ER -